Long‐term patterns of safety and efficacy of bleeding prophylaxis with turoctocog alfa (NovoEight®) in previously treated patients with severe haemophilia A: interim results of the guardian™2 extension trial

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2516|1351-8216|5|e436-e439

ISSN: 1351-8216

Source: HAEMOPHILIA, Vol.1351-8216, Iss.5, 2015-09, pp. : e436-e439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract